Innovative Medicine Market, Global Outlook and Forecast 2022-2028

July 2022 | 108 pages | ID: I59679372E9EEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Innovative Medicine in Global, including the following market information:

Global Innovative Medicine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Innovative Medicine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Biological Medicine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Innovative Medicine include Pfizer, Roche, Sanofi, Johnson & Johnson, Merck & Co., Novartis, AbbVie, Gilead Sciences and GlaxoSmithKline, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Innovative Medicine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Innovative Medicine Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Innovative Medicine Market Segment Percentages, by Type, 2021 (%)

• Biological Medicine
• Chemical Medicine

Global Innovative Medicine Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Innovative Medicine Market Segment Percentages, by Application, 2021 (%)

• Oncology
• Neurosciences
• Immunology
• Respiratory
• Others

Global Innovative Medicine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Innovative Medicine Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Innovative Medicine revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Innovative Medicine revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Roche
• Sanofi
• Johnson & Johnson
• Merck & Co.
• Novartis
• AbbVie
• Gilead Sciences
• GlaxoSmithKline
• Amgen
• AstraZeneca
• Bristol-Myers Squibb
• Eli Lilly
• Bayer
• Novo Nordisk
• Allergan
• Takeda
• Boehringer Ingelheim

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Innovative Medicine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Innovative Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL INNOVATIVE MEDICINE OVERALL MARKET SIZE

2.1 Global Innovative Medicine Market Size: 2021 VS 2028
2.2 Global Innovative Medicine Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Innovative Medicine Players in Global Market
3.2 Top Global Innovative Medicine Companies Ranked by Revenue
3.3 Global Innovative Medicine Revenue by Companies
3.4 Top 3 and Top 5 Innovative Medicine Companies in Global Market, by Revenue in 2021
3.5 Global Companies Innovative Medicine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Innovative Medicine Players in Global Market
  3.6.1 List of Global Tier 1 Innovative Medicine Companies
  3.6.2 List of Global Tier 2 and Tier 3 Innovative Medicine Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Innovative Medicine Market Size Markets, 2021 & 2028
  4.1.2 Biological Medicine
  4.1.3 Chemical Medicine
4.2 By Type - Global Innovative Medicine Revenue & Forecasts
  4.2.1 By Type - Global Innovative Medicine Revenue, 2017-2022
  4.2.2 By Type - Global Innovative Medicine Revenue, 2023-2028
  4.2.3 By Type - Global Innovative Medicine Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Innovative Medicine Market Size, 2021 & 2028
  5.1.2 Oncology
  5.1.3 Neurosciences
  5.1.4 Immunology
  5.1.5 Respiratory
  5.1.6 Others
5.2 By Application - Global Innovative Medicine Revenue & Forecasts
  5.2.1 By Application - Global Innovative Medicine Revenue, 2017-2022
  5.2.2 By Application - Global Innovative Medicine Revenue, 2023-2028
  5.2.3 By Application - Global Innovative Medicine Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Innovative Medicine Market Size, 2021 & 2028
6.2 By Region - Global Innovative Medicine Revenue & Forecasts
  6.2.1 By Region - Global Innovative Medicine Revenue, 2017-2022
  6.2.2 By Region - Global Innovative Medicine Revenue, 2023-2028
  6.2.3 By Region - Global Innovative Medicine Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Innovative Medicine Revenue, 2017-2028
  6.3.2 US Innovative Medicine Market Size, 2017-2028
  6.3.3 Canada Innovative Medicine Market Size, 2017-2028
  6.3.4 Mexico Innovative Medicine Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Innovative Medicine Revenue, 2017-2028
  6.4.2 Germany Innovative Medicine Market Size, 2017-2028
  6.4.3 France Innovative Medicine Market Size, 2017-2028
  6.4.4 U.K. Innovative Medicine Market Size, 2017-2028
  6.4.5 Italy Innovative Medicine Market Size, 2017-2028
  6.4.6 Russia Innovative Medicine Market Size, 2017-2028
  6.4.7 Nordic Countries Innovative Medicine Market Size, 2017-2028
  6.4.8 Benelux Innovative Medicine Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Innovative Medicine Revenue, 2017-2028
  6.5.2 China Innovative Medicine Market Size, 2017-2028
  6.5.3 Japan Innovative Medicine Market Size, 2017-2028
  6.5.4 South Korea Innovative Medicine Market Size, 2017-2028
  6.5.5 Southeast Asia Innovative Medicine Market Size, 2017-2028
  6.5.6 India Innovative Medicine Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Innovative Medicine Revenue, 2017-2028
  6.6.2 Brazil Innovative Medicine Market Size, 2017-2028
  6.6.3 Argentina Innovative Medicine Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Innovative Medicine Revenue, 2017-2028
  6.7.2 Turkey Innovative Medicine Market Size, 2017-2028
  6.7.3 Israel Innovative Medicine Market Size, 2017-2028
  6.7.4 Saudi Arabia Innovative Medicine Market Size, 2017-2028
  6.7.5 UAE Innovative Medicine Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Innovative Medicine Major Product Offerings
  7.1.4 Pfizer Innovative Medicine Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 Roche
  7.2.1 Roche Corporate Summary
  7.2.2 Roche Business Overview
  7.2.3 Roche Innovative Medicine Major Product Offerings
  7.2.4 Roche Innovative Medicine Revenue in Global Market (2017-2022)
  7.2.5 Roche Key News
7.3 Sanofi
  7.3.1 Sanofi Corporate Summary
  7.3.2 Sanofi Business Overview
  7.3.3 Sanofi Innovative Medicine Major Product Offerings
  7.3.4 Sanofi Innovative Medicine Revenue in Global Market (2017-2022)
  7.3.5 Sanofi Key News
7.4 Johnson & Johnson
  7.4.1 Johnson & Johnson Corporate Summary
  7.4.2 Johnson & Johnson Business Overview
  7.4.3 Johnson & Johnson Innovative Medicine Major Product Offerings
  7.4.4 Johnson & Johnson Innovative Medicine Revenue in Global Market (2017-2022)
  7.4.5 Johnson & Johnson Key News
7.5 Merck & Co.
  7.5.1 Merck & Co. Corporate Summary
  7.5.2 Merck & Co. Business Overview
  7.5.3 Merck & Co. Innovative Medicine Major Product Offerings
  7.5.4 Merck & Co. Innovative Medicine Revenue in Global Market (2017-2022)
  7.5.5 Merck & Co. Key News
7.6 Novartis
  7.6.1 Novartis Corporate Summary
  7.6.2 Novartis Business Overview
  7.6.3 Novartis Innovative Medicine Major Product Offerings
  7.6.4 Novartis Innovative Medicine Revenue in Global Market (2017-2022)
  7.6.5 Novartis Key News
7.7 AbbVie
  7.7.1 AbbVie Corporate Summary
  7.7.2 AbbVie Business Overview
  7.7.3 AbbVie Innovative Medicine Major Product Offerings
  7.7.4 AbbVie Innovative Medicine Revenue in Global Market (2017-2022)
  7.7.5 AbbVie Key News
7.8 Gilead Sciences
  7.8.1 Gilead Sciences Corporate Summary
  7.8.2 Gilead Sciences Business Overview
  7.8.3 Gilead Sciences Innovative Medicine Major Product Offerings
  7.8.4 Gilead Sciences Innovative Medicine Revenue in Global Market (2017-2022)
  7.8.5 Gilead Sciences Key News
7.9 GlaxoSmithKline
  7.9.1 GlaxoSmithKline Corporate Summary
  7.9.2 GlaxoSmithKline Business Overview
  7.9.3 GlaxoSmithKline Innovative Medicine Major Product Offerings
  7.9.4 GlaxoSmithKline Innovative Medicine Revenue in Global Market (2017-2022)
  7.9.5 GlaxoSmithKline Key News
7.10 Amgen
  7.10.1 Amgen Corporate Summary
  7.10.2 Amgen Business Overview
  7.10.3 Amgen Innovative Medicine Major Product Offerings
  7.10.4 Amgen Innovative Medicine Revenue in Global Market (2017-2022)
  7.10.5 Amgen Key News
7.11 AstraZeneca
  7.11.1 AstraZeneca Corporate Summary
  7.11.2 AstraZeneca Business Overview
  7.11.3 AstraZeneca Innovative Medicine Major Product Offerings
  7.11.4 AstraZeneca Innovative Medicine Revenue in Global Market (2017-2022)
  7.11.5 AstraZeneca Key News
7.12 Bristol-Myers Squibb
  7.12.1 Bristol-Myers Squibb Corporate Summary
  7.12.2 Bristol-Myers Squibb Business Overview
  7.12.3 Bristol-Myers Squibb Innovative Medicine Major Product Offerings
  7.12.4 Bristol-Myers Squibb Innovative Medicine Revenue in Global Market (2017-2022)
  7.12.5 Bristol-Myers Squibb Key News
7.13 Eli Lilly
  7.13.1 Eli Lilly Corporate Summary
  7.13.2 Eli Lilly Business Overview
  7.13.3 Eli Lilly Innovative Medicine Major Product Offerings
  7.13.4 Eli Lilly Innovative Medicine Revenue in Global Market (2017-2022)
  7.13.5 Eli Lilly Key News
7.14 Bayer
  7.14.1 Bayer Corporate Summary
  7.14.2 Bayer Business Overview
  7.14.3 Bayer Innovative Medicine Major Product Offerings
  7.14.4 Bayer Innovative Medicine Revenue in Global Market (2017-2022)
  7.14.5 Bayer Key News
7.15 Novo Nordisk
  7.15.1 Novo Nordisk Corporate Summary
  7.15.2 Novo Nordisk Business Overview
  7.15.3 Novo Nordisk Innovative Medicine Major Product Offerings
  7.15.4 Novo Nordisk Innovative Medicine Revenue in Global Market (2017-2022)
  7.15.5 Novo Nordisk Key News
7.16 Allergan
  7.16.1 Allergan Corporate Summary
  7.16.2 Allergan Business Overview
  7.16.3 Allergan Innovative Medicine Major Product Offerings
  7.16.4 Allergan Innovative Medicine Revenue in Global Market (2017-2022)
  7.16.5 Allergan Key News
7.17 Takeda
  7.17.1 Takeda Corporate Summary
  7.17.2 Takeda Business Overview
  7.17.3 Takeda Innovative Medicine Major Product Offerings
  7.17.4 Takeda Innovative Medicine Revenue in Global Market (2017-2022)
  7.17.5 Takeda Key News
7.18 Boehringer Ingelheim
  7.18.1 Boehringer Ingelheim Corporate Summary
  7.18.2 Boehringer Ingelheim Business Overview
  7.18.3 Boehringer Ingelheim Innovative Medicine Major Product Offerings
  7.18.4 Boehringer Ingelheim Innovative Medicine Revenue in Global Market (2017-2022)
  7.18.5 Boehringer Ingelheim Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Innovative Medicine Market Opportunities & Trends in Global Market
Table 2. Innovative Medicine Market Drivers in Global Market
Table 3. Innovative Medicine Market Restraints in Global Market
Table 4. Key Players of Innovative Medicine in Global Market
Table 5. Top Innovative Medicine Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Innovative Medicine Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Innovative Medicine Revenue Share by Companies, 2017-2022
Table 8. Global Companies Innovative Medicine Product Type
Table 9. List of Global Tier 1 Innovative Medicine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Innovative Medicine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Innovative Medicine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Innovative Medicine Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Innovative Medicine Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Innovative Medicine Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Innovative Medicine Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Innovative Medicine Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Innovative Medicine Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Innovative Medicine Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Innovative Medicine Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Innovative Medicine Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Innovative Medicine Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Innovative Medicine Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Innovative Medicine Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Innovative Medicine Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Innovative Medicine Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Innovative Medicine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Innovative Medicine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Innovative Medicine Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Innovative Medicine Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Innovative Medicine Product Offerings
Table 32. Pfizer Innovative Medicine Revenue (US$, Mn), (2017-2022)
Table 33. Roche Corporate Summary
Table 34. Roche Innovative Medicine Product Offerings
Table 35. Roche Innovative Medicine Revenue (US$, Mn), (2017-2022)
Table 36. Sanofi Corporate Summary
Table 37. Sanofi Innovative Medicine Product Offerings
Table 38. Sanofi Innovative Medicine Revenue (US$, Mn), (2017-2022)
Table 39. Johnson & Johnson Corporate Summary
Table 40. Johnson & Johnson Innovative Medicine Product Offerings
Table 41. Johnson & Johnson Innovative Medicine Revenue (US$, Mn), (2017-2022)
Table 42. Merck & Co. Corporate Summary
Table 43. Merck & Co. Innovative Medicine Product Offerings
Table 44. Merck & Co. Innovative Medicine Revenue (US$, Mn), (2017-2022)
Table 45. Novartis Corporate Summary
Table 46. Novartis Innovative Medicine Product Offerings
Table 47. Novartis Innovative Medicine Revenue (US$, Mn), (2017-2022)
Table 48. AbbVie Corporate Summary
Table 49. AbbVie Innovative Medicine Product Offerings
Table 50. AbbVie Innovative Medicine Revenue (US$, Mn), (2017-2022)
Table 51. Gilead Sciences Corporate Summary
Table 52. Gilead Sciences Innovative Medicine Product Offerings
Table 53. Gilead Sciences Innovative Medicine Revenue (US$, Mn), (2017-2022)
Table 54. GlaxoSmithKline Corporate Summary
Table 55. GlaxoSmithKline Innovative Medicine Product Offerings
Table 56. GlaxoSmithKline Innovative Medicine Revenue (US$, Mn), (2017-2022)
Table 57. Amgen Corporate Summary
Table 58. Amgen Innovative Medicine Product Offerings
Table 59. Amgen Innovative Medicine Revenue (US$, Mn), (2017-2022)
Table 60. AstraZeneca Corporate Summary
Table 61. AstraZeneca Innovative Medicine Product Offerings
Table 62. AstraZeneca Innovative Medicine Revenue (US$, Mn), (2017-2022)
Table 63. Bristol-Myers Squibb Corporate Summary
Table 64. Bristol-Myers Squibb Innovative Medicine Product Offerings
Table 65. Bristol-Myers Squibb Innovative Medicine Revenue (US$, Mn), (2017-2022)
Table 66. Eli Lilly Corporate Summary
Table 67. Eli Lilly Innovative Medicine Product Offerings
Table 68. Eli Lilly Innovative Medicine Revenue (US$, Mn), (2017-2022)
Table 69. Bayer Corporate Summary
Table 70. Bayer Innovative Medicine Product Offerings
Table 71. Bayer Innovative Medicine Revenue (US$, Mn), (2017-2022)
Table 72. Novo Nordisk Corporate Summary
Table 73. Novo Nordisk Innovative Medicine Product Offerings
Table 74. Novo Nordisk Innovative Medicine Revenue (US$, Mn), (2017-2022)
Table 75. Allergan Corporate Summary
Table 76. Allergan Innovative Medicine Product Offerings
Table 77. Allergan Innovative Medicine Revenue (US$, Mn), (2017-2022)
Table 78. Takeda Corporate Summary
Table 79. Takeda Innovative Medicine Product Offerings
Table 80. Takeda Innovative Medicine Revenue (US$, Mn), (2017-2022)
Table 81. Boehringer Ingelheim Corporate Summary
Table 82. Boehringer Ingelheim Innovative Medicine Product Offerings
Table 83. Boehringer Ingelheim Innovative Medicine Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Innovative Medicine Segment by Type in 2021
Figure 2. Innovative Medicine Segment by Application in 2021
Figure 3. Global Innovative Medicine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Innovative Medicine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Innovative Medicine Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Innovative Medicine Revenue in 2021
Figure 8. By Type - Global Innovative Medicine Revenue Market Share, 2017-2028
Figure 9. By Application - Global Innovative Medicine Revenue Market Share, 2017-2028
Figure 10. By Region - Global Innovative Medicine Revenue Market Share, 2017-2028
Figure 11. By Country - North America Innovative Medicine Revenue Market Share, 2017-2028
Figure 12. US Innovative Medicine Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Innovative Medicine Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Innovative Medicine Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Innovative Medicine Revenue Market Share, 2017-2028
Figure 16. Germany Innovative Medicine Revenue, (US$, Mn), 2017-2028
Figure 17. France Innovative Medicine Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Innovative Medicine Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Innovative Medicine Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Innovative Medicine Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Innovative Medicine Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Innovative Medicine Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Innovative Medicine Revenue Market Share, 2017-2028
Figure 24. China Innovative Medicine Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Innovative Medicine Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Innovative Medicine Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Innovative Medicine Revenue, (US$, Mn), 2017-2028
Figure 28. India Innovative Medicine Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Innovative Medicine Revenue Market Share, 2017-2028
Figure 30. Brazil Innovative Medicine Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Innovative Medicine Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Innovative Medicine Revenue Market Share, 2017-2028
Figure 33. Turkey Innovative Medicine Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Innovative Medicine Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Innovative Medicine Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Innovative Medicine Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Innovative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Roche Innovative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Sanofi Innovative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Johnson & Johnson Innovative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merck & Co. Innovative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novartis Innovative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. AbbVie Innovative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Gilead Sciences Innovative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. GlaxoSmithKline Innovative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Amgen Innovative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. AstraZeneca Innovative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Bristol-Myers Squibb Innovative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Eli Lilly Innovative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Bayer Innovative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Novo Nordisk Innovative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Allergan Innovative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Takeda Innovative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Boehringer Ingelheim Innovative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)